ReviewCirculation research2026
Decoding Vascular Cell Diversity: Single-Cell Approaches to Mechanisms of Vascular Disease.
Review in Circulation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Almost 200 years of histological and molecular analysis has established that functional shifts in vascular cell populations are associated with healthy vascular function and the progression of vascular disease. Now, new methods in single-cell analysis are serving to dramatically accelerate the study of vascular cell heterogeneity. Here, we will outline the experimental and computational technologies that have made high-throughput analysis of single cells possible, and review recent studies applying these approaches to vascular cells and tissues. In particular, the application of single-cell or single-nucleus RNA sequencing has identified rare and disease-specific cell populations, drivers of cellular heterogeneity, and specific vascular disease-relevant cell populations. High-throughput approaches linking CRISPR (clustered regularly interspaced short palindromic repeats) perturbations to single-cell RNA sequencing data are providing new insights into cell type-specific mechanisms of disease, and connecting human genetic data to these mechanisms. Other single-cell approaches are providing insights into regulatory mechanisms by linking chromatin accessibility to transcription in single cells and revealing the spatial positioning of rare cell types in vascular tissues. With a variety of well-established methods and the continued development of new technologies, single-cell approaches are becoming indispensable and powerful avenues for discovering and detailing new mechanisms of vascular disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.